Condition: Granulomatosis With Polyangiitis · Microscopic Polyangiitis (MPA) · Sponsor: Ottawa Hospital Research Institute
The purpose of this study is to determine the safety and efficacy of a therapeutic regimen consisting of 4 weeks of glucocorticoids given with a combination of the usual induction agents for ANCA-associated vasculitis. The trial will compare this regimen to the current standard of care treatment and glucocorticoid dosing for ANCA-associated vasculitis with severe kidney involvement. This trial will begin as a pilot to assess feasibility of recruitment and of adherence to the intervention.
This description comes directly from the study's public registry record.
David Massicotte-Azarniouch, MD, MSc · 613-738-8400 · damassicotte@toh.ca
Always discuss trial participation with your own doctor first.
| St-Joseph's Hospital | Hamilton, Ontario, Canada | Not Yet Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06983821